There were 1,863 press releases posted in the last 24 hours and 406,279 in the last 365 days.

Dr. Aaron Rossi: Reditus Laboratories - The other side of the story

Dr. Aaron Rossi Under Attack CEO Reditus Labs

Dr. Aaron Rossi

Reditus Labs Logo

Dr. James Davie's Non-Compete Agreement, Davie & Associates Dermatopathology vs. PROMUS DIAGNOSTIC/BIOSOLUTIONS LLC,DLP SERVICE GROUP LLC,BIOLAB HOLDINGS LLC,MRF LAB HOLDINGS LLC

Dr. James Davie's Non-Compete Agreement with Promus Diagnostic

A non-compete agreement has surfaced in favor of Reditus Laboratories CEO Dr. Aaron Rossi.

The allegations against Dr. Aaron Rossi appear to be one sided!”
— Phillip Turner - FNN

PEKIN, IL, USA, April 29, 2022 /EINPresswire.com/ -- Dr. Aaron Rossi is the CEO of Reditus Laboratories and PAL Health Technologies, overseeing the growth, direction and success of the two Pekin-based companies. Reditus Laboratories is a full-service laboratory company with a heavy focus on molecular diagnostics, while PAL Health is a national leader in the fabrication of custom orthotics, shoe inserts, and other corrective foot and ankle devices. Under Dr. Rossi’s direction, both have garnered recognition for their above-and-beyond efforts to help combat the COVID-19 pandemic.

New 7, based out of Phoenix, AZ conducted an interview with Phillip Turner. In this interview, the non-compete agreement between Davie & Associates Dermatopathology (owned by Dr. James Davie) and Promus Diagnostic (Southlake, TX) was highlighted in order to show that Dr. Davie was under a non-compete agreement prior to dealing with Reditus Laboratories. The non-complete agreement was obtained from the Tarrant County (Texas) courthouse. At this time, Dr. Davie's Plano, TX based company, Davie & Associates Dermatopathology, is in a lawsuit with Promus Diagnostic/Biosolutions LLC, DLP Service Group LLC, Bio Lab Holdings LLC and MRF Lab Holdings LLC (JP03-21-SC00025317 - Tarrant County, Texas).

According to Phillip Turner, Dr. James Davie filed two cases against Dr. Aaron Rossi which were non-suited because of lack of standing. The non-compete agreement that Dr. Davie had in place is a factor in these cases being dismissed. It is critical to get to the bottom of the other side of the story because the without this transparency, the public will have a difficult time understanding the facts.

James Williams
JS2 Media
email us here

Reditus Labs CEO Aaron Rossi - The Other Side Of The Story

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.